Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -43737.46% is 44% below its 5-year average of -30307.75%, near the high end of its 5-year range (-250321.79%–0.00%).
0.26% below its 12-month average of -43623.36%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -27950.50%.
OPERATING MARGIN
-43737.46%
OPERATING MARGIN AVG TTM
-43623.36%
OPERATING MARGIN AVG 3Y
-32634.27%
OPERATING MARGIN AVG 5Y
-30307.75%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.26%
CURRENT VS 3Y AVG
-34.02%
CURRENT VS 5Y AVG
-44.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 495 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cardio Diagnostics Holdings, Inc.
Market Cap
$6.10M
Operating Margin
-43737.46%
TTM Avg
-43623.36%
3Y Avg
-32634.27%
5Y Avg
-30307.75%
Market Cap
$6.10M
Operating Margin
-763.90%
TTM Avg
-929.35%
3Y Avg
-1043.46%
5Y Avg
-924.75%
Market Cap
$6.09M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-71.62%
Market Cap
$6.03M
Operating Margin
-9154.62%
TTM Avg
-6279.74%
3Y Avg
-3924.25%
5Y Avg
-3328.36%
Market Cap
$6.34M
Operating Margin
-119.54%
TTM Avg
-108.09%
3Y Avg
-117.27%
5Y Avg
-99.55%
Market Cap
$6.44M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.63M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.54M
Operating Margin
-305.03%
TTM Avg
-323.91%
3Y Avg
-495.10%
5Y Avg
-376.97%
Market Cap
$6.72M
Operating Margin
-450.07%
TTM Avg
-699.99%
3Y Avg
-986.00%
5Y Avg
-5433.17%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | $6.10M | -43737.46% | -43623.36% | -32634.27% | -30307.75% |
| Femasys Inc. (FEMY)vs › | $6.10M | -763.90% | -929.35% | -1043.46% | -924.75% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 0.00% | 0.00% | 0.00% | -71.62% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | -9154.62% | -6279.74% | -3924.25% | -3328.36% |
| Biomerica, Inc. (BMRA)vs › | $6.34M | -119.54% | -108.09% | -117.27% | -99.55% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.54M | -305.03% | -323.91% | -495.10% | -376.97% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | -450.07% | -699.99% | -986.00% | -5433.17% |
| Aclarion, Inc. (ACON)vs › | $6.74M | -9312.55% | -10684.89% | -9259.36% | -8523.06% |
Gross Margin
100.0%
Operating Margin
-43737.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -27950.50% |
| 2026-03-31 | -66598.40% |
| 2025-12-31 | -41159.55% |
| 2025-09-30 | -59950.86% |
| 2025-06-30 | -22457.51% |
| 2025-03-31 | -173463.83% |
| 2024-12-31 | -33608.20% |
| 2024-09-30 | -21412.87% |
| 2024-06-30 | -16295.55% |
| 2024-03-31 | -26105.27% |
| 2023-12-31 | -29039.51% |
| 2023-09-30 | -14398.71% |
| 2023-06-30 | -148008.17% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -250321.79% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | -68862.15% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
